DE3782686T2 - Zusammensetzungen zur vorbeugung von plastik-abstossung. - Google Patents

Zusammensetzungen zur vorbeugung von plastik-abstossung.

Info

Publication number
DE3782686T2
DE3782686T2 DE8787108976T DE3782686T DE3782686T2 DE 3782686 T2 DE3782686 T2 DE 3782686T2 DE 8787108976 T DE8787108976 T DE 8787108976T DE 3782686 T DE3782686 T DE 3782686T DE 3782686 T2 DE3782686 T2 DE 3782686T2
Authority
DE
Germany
Prior art keywords
rejection
heparin
compositions
prevent plastic
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787108976T
Other languages
English (en)
Other versions
DE3782686D1 (de
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE3782686D1 publication Critical patent/DE3782686D1/de
Publication of DE3782686T2 publication Critical patent/DE3782686T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
DE8787108976T 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastik-abstossung. Expired - Fee Related DE3782686T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (2)

Publication Number Publication Date
DE3782686D1 DE3782686D1 (de) 1992-12-24
DE3782686T2 true DE3782686T2 (de) 1993-06-09

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787108976T Expired - Fee Related DE3782686T2 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastik-abstossung.

Country Status (10)

Country Link
EP (1) EP0251134B1 (de)
JP (1) JP2527749B2 (de)
AT (1) ATE82502T1 (de)
AU (1) AU608228B2 (de)
DE (1) DE3782686T2 (de)
DK (1) DK169422B1 (de)
ES (1) ES2052514T3 (de)
GR (1) GR3006814T3 (de)
IL (1) IL79254A0 (de)
NO (1) NO872675L (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
DE69835016T2 (de) * 1997-07-14 2007-06-28 Muramatsu, Takashi, Nagoya Verwendung von midkin oder von anti-midkin antikörper
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
MXPA04002217A (es) 2001-09-12 2004-07-08 Sigma Tau Ind Farmaceuti Derivados de glucosaminoglucanas parcialmente desulfatados como inhibidores de heparanasa, dotados con actividad antiangiogenica y libres de efectos anticoagulantes.
EP1748781B1 (de) 2004-05-27 2012-12-19 Baxter International Inc. Verfahren zur behandlung von blutungsstörungen mittels sulfatierter polysaccharide
EP2326334A2 (de) 2008-08-22 2011-06-01 Baxter Healthcare SA Verfahren zur behandlung von blutungsstörungen
AU2011205271B2 (en) 2010-01-14 2014-01-30 Baxalta GmbH Methods and compositions for treating bleeding disorders
WO2013012954A2 (en) 2011-07-19 2013-01-24 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
EP2885642B1 (de) 2012-08-14 2019-05-15 Baxalta GmbH Verfahren und systeme zum screening von zusammensetzungen mit nicht gerinnenden sulfatierten polysacchariden
US9265791B2 (en) 2013-03-12 2016-02-23 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
CN108367023B (zh) * 2015-06-11 2021-04-20 马斯特里赫特大学 预防宿主中移植物衰竭的方法

Also Published As

Publication number Publication date
JPS6388127A (ja) 1988-04-19
JP2527749B2 (ja) 1996-08-28
ATE82502T1 (de) 1992-12-15
NO872675D0 (no) 1987-06-25
GR3006814T3 (de) 1993-06-30
ES2052514T3 (es) 1994-07-16
DK169422B1 (da) 1994-10-31
AU608228B2 (en) 1991-03-28
EP0251134B1 (de) 1992-11-19
IL79254A0 (en) 1986-09-30
EP0251134A3 (en) 1989-05-03
DE3782686D1 (de) 1992-12-24
AU7470687A (en) 1988-01-07
EP0251134A2 (de) 1988-01-07
DK331287D0 (da) 1987-06-26
NO872675L (no) 1987-12-28
DK331287A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
DE3782686T2 (de) Zusammensetzungen zur vorbeugung von plastik-abstossung.
DE3587266T2 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ES2152998T3 (es) Agente anticomplementario obtenido a partir de fucanos de algas pardas.
ATE122542T1 (de) Essbare plastische dispersion.
ATE190496T1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE3889536T2 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
ATE106737T1 (de) Pharmazeutische zusammensetzungen zur behandlung gastrointestinaler störungen.
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ES2106042T3 (es) Inhibidores de la incorporacion de calcio.
BR8701968A (pt) Componente feito de um material polimero injetavel ou fundivel
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE68917817D1 (de) Verfahren zur Herstellung von vernetzten Polycarbonaten und Zusammensetzungen daraus.
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
Kaiser Importance of corticosteroids in the treatment of infectious diseases.
ATE96039T1 (de) Arzneimittel und ihre verwendung zur behandlung von parasitosen.
ATE161183T1 (de) Heparinneutralisierung durch blutplättchenfaktor
DE68904195D1 (de) Paromomycin oder seine derivate zur parenteralen behandlung von parasitaeren erkrankungen beim menschen.
ATE55252T1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: YEDA RESEARCH AND DEVELOPMENT CO., LTD., REHOVOT, IL

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee